Trujillo, Paula http://orcid.org/0000-0001-9753-7071
Song, Alexander K.
Hay, Kaitlyn R.
Aumann, Megan http://orcid.org/0000-0002-3924-8455
Yan, Yan http://orcid.org/0000-0002-0455-7450
Kang, Hakmook
Donahue, Manus J.
Claassen, Daniel O.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS097783, K23NS080988)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR000445)
Article History
Received: 23 July 2021
Accepted: 1 February 2022
First Online: 5 April 2022
Competing interests
: The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. P.T. is a paid consultant for Alterity. M.J.D. is a paid consultant for Pfizer, Global Blood Therapeutics, Spark Therapeutics, LymphaTouch, and Alterity and has served on advisory boards for Novartis and bluebird bio. He receives research grant funding from the National Institutes of Health and Pfizer, research-related support from Philips Healthcare, and is the CEO of Biosight LLC which operates as a contracted Clinical Research Organization. D.O.C. receives research support from the Griffin Foundation, the Huntington’s Disease Society of America, the National Institute of Neurological Disorders and Stroke, National Institute on Aging, National Center for Complementary and Integrative Health, and Department of Defense; he received pharmaceutical grant support from AbbVie, Acadia, Biogen, BMS, Cerecour, Eli Lilly, Genetech/Roche, PTC Therapeutics, Lundbeck, Jazz Pharmaceuticals, Teva Neuroscience, Spark, Wave Life Sciences, and Vaccinex; currently receives grant support from Genentech/ Roche, AbbVie, Prilenia, Alterity, AbbVie, and CHDI, and he has served as a consultant to or on the advisory board of Acadia, Alterity, Adamas, Lundbeck, Neurocrine, Photopharmics, and Teva Neuroscience.